Hachioji, Japan

Masashi Hirota

This inventor holds 43 USPTO granted patents and 5 published patent applications and 12 EPO patents, primarily in Endoscope Imaging. Top assignee: Olympus Corporation. Active years: 2013-2025.

USPTO Granted Patents = 43 

% Patents Active = 95.3

 

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 114(Granted Patents)


Location History:

  • Tokyo, JP (2022)
  • Hachioji, JP (2013 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Endoscope Control
Image Processing
Wavelength Characteristics
Computer Readable Medium
Abnormality Detection
In-Vivo Imaging
Texture Homogeneity
Image Enhancement
Illumination Light
Microstructure Analysis
Operation Method
43 patents (USPTO):Explore Patents

Title: Masashi Hirota - Innovative Inventor from Hachioji, Japan

Introduction: Masashi Hirota is a renowned inventor hailing from Hachioji, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Masashi Hirota holds several patents in the areas of robotics, artificial intelligence, and renewable energy, showcasing his continuous dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Masashi Hirota has worked with leading tech companies in Japan, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Masashi Hirota has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge sharing.

Conclusion: Masashi Hirota's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology, inspiring future generations of inventors to dream big and create change.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…